ASCO20: What was the background and study design of the SPARTAN study?

Eric Small | Onkologi /hematologi | ASCO20 Virtual | Juni 3, 2020

Speaker: Eric Small

Eric J. Small, MD and principal investigator of the SPARTAN study here explains the background and study design of the SPARTAN study, where the efficiency and safety of apalutamide for patients with nonmetastatic castration-resistant prostate cancer (nmCRPC).